Additionally, future research in periodontitis should focus on the investigation of specific cellular mechanisms and further develop targeted therapies that enable selective inhibition of IL-17 in specific cell types or contexts, such as osteoclast precursors or the early stages of the disease, thereby helping to mitigate bone loss without impairing bone regeneration or protection. Here, IL17A is linked to periodontitis.